Literature DB >> 15865019

Is the lateral lymph node compartment relevant?

Moritz Koch1, Peter Kienle, Dalibor Antolovic, Markus W Büchler, Jürgen Weitz.   

Abstract

Lateral pelvic lymphadenectomy is routinely performed in advanced lower rectal cancers by Japanese surgeons, whereas in the western world it has not progressed to a frequently performed technique. Claimed benefit for this extensive surgery is an improved locoregional control; on the other hand, low positive lateral lymph node yields, questionable prognostic significance, and high morbidity (urinary and sexual dysfunction) are main reasons against this procedure. Clinical results published on lateral lymphadenectomy in the literature are conflicting. Due to major improvements in local control and survival of rectal cancer patients mainly based on preoperative radiotherapy and total mesorectal excision (TME), only a few patients may profit from lateral lymph node dissection. This article gives an overview of the current status and the clinical relevance of the lateral lymph node compartment in rectal cancer surgery.

Entities:  

Mesh:

Year:  2005        PMID: 15865019     DOI: 10.1007/3-540-27449-9_6

Source DB:  PubMed          Journal:  Recent Results Cancer Res        ISSN: 0080-0015


  13 in total

Review 1.  [Surgery for rectal cancer].

Authors:  C J Krones; M Stumpf; V Schumpelick
Journal:  Chirurg       Date:  2009-04       Impact factor: 0.955

2.  Factors associated with lateral pelvic recurrence after curative resection following neoadjuvant chemoradiotherapy in rectal cancer patients.

Authors:  Tae Gyu Kim; Won Park; Doo Ho Choi; Hee Chul Park; Seok-Hyung Kim; Yong Beom Cho; Seong Hyeon Yun; Hee Cheol Kim; Woo Yong Lee; Jeeyun Lee; Joon Oh Park; Young Suk Park; Ho Yeong Lim; Won Ki Kang; Ho-Kyung Chun
Journal:  Int J Colorectal Dis       Date:  2013-12-10       Impact factor: 2.571

3.  Impact of Lateral Pelvic Lymph Node Dissection on the Survival of Patients with T3 and T4 Low Rectal Cancer.

Authors:  Heita Ozawa; Kenjiro Kotake; Miki Hosaka; Akira Hirata; Kenichi Sugihara
Journal:  World J Surg       Date:  2016-06       Impact factor: 3.352

4.  Improving prediction of lateral node spread in low rectal cancers--multivariate analysis of clinicopathological factors in 1,046 cases.

Authors:  Kok-Yang Tan; Seiichiro Yamamoto; Shin Fujita; Takayuki Akasu; Yoshihiro Moriya
Journal:  Langenbecks Arch Surg       Date:  2010-04-02       Impact factor: 3.445

Review 5.  The role of lateral lymph node dissection in the management of lower rectal cancer.

Authors:  Ziting Wang; Kep Yong Loh; Kok-Yang Tan; Emile Chung-Hou Woo
Journal:  Langenbecks Arch Surg       Date:  2011-11-22       Impact factor: 3.445

6.  Study of therapeutic results, lymph node ratio, short-term and long-term complications of lateral lymph node dissection in rectal cancer patients.

Authors:  Habibollah Mahmoodzadeh; Ramesh Omranipour; Anahita Borjian; Mohammad Amin Borjian
Journal:  Turk J Surg       Date:  2020-06-08

7.  Regional lymph node metastasis and locoregional recurrence of rectal carcinoma in the era of TME [corrected] surgery. Implications for treatment decisions.

Authors:  Paul Hermanek; Susanne Merkel; Rainer Fietkau; Claus Rödel; Werner Hohenberger
Journal:  Int J Colorectal Dis       Date:  2009-12-10       Impact factor: 2.571

8.  Management of locally advanced primary and recurrent rectal cancer.

Authors:  Johannes H W de Wilt; Maarten Vermaas; Floris T J Ferenschild; Cornelis Verhoef
Journal:  Clin Colon Rectal Surg       Date:  2007-08

9.  Prognostic value of lateral lymph node metastasis for advanced low rectal cancer.

Authors:  Ze-Yu Wu; Jin Wan; Jing-Hua Li; Gang Zhao; Yuan Yao; Jia-Lin Du; Quan-Fang Liu; Lin Peng; Zhi-Du Wang; Zhi-Ming Huang; Hua-Huan Lin
Journal:  World J Gastroenterol       Date:  2007-12-07       Impact factor: 5.742

10.  Review of histopathological and molecular prognostic features in colorectal cancer.

Authors:  Ola Marzouk; John Schofield
Journal:  Cancers (Basel)       Date:  2011-06-23       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.